Hims and Hers Health Inc vs Pfizer Inc — how do they compare? Hims and Hers Health Inc trades at $30.63 (market cap $7.12B), while Pfizer Inc trades at $26.51 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 21.3× Hims and Hers Health Inc's market cap, and Pfizer Inc pays a 6.46% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | PFE | |
|---|---|---|
Market Cap | $7.12B | $151.73B |
Sector | Health | Health |
52-Week High | $62.76 | $28.56 |
52-Week Low | $14.52 | $23.60 |
Enterprise Value | $7.82B | $203.22B |
Volume | — | 29,869,932 |
Dividend Yield | — | 6.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Trailing returns across standard periods
Latest headlines on both assets
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →